Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain. We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34,35).”
From A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705 · cited 1×
“With this approach, it is easy to show that elevated NEFA concentrations are associated acutely with insulin resistance, both with peripheral glucose uptake (33,34) and hepatic gluconeogenesis (35,36) and with impaired glucose tolerance (37).”
BackgroundA RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE
Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,454 · cited 1×
“Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health.”
BackgroundRomijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747 · cited 1×
“somewhat (2), but often plasma NEFA concentrations remain relatively stable as removal by muscle increases to match adipose tissue lipolysis (27,28).”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 1×
“The detrimental effects on insulin sensitivity and other cellular processes are known as lipotoxicity (57).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The abdominal subcutaneous fat depot is the dominant source of NEFA; considerably less comes from leg adipose tissue and—against popular belief—only a small proportion of the systemic NEFA concentrations arises from intraabdominal adipose tissue (7).”
BackgroundLipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826 · cited 1×
“It has been reviewed recently (8), and we will not cover those aspects here.”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“The rationale for this supposition comes from the fact that adipose tissue could be seen as insulin resistant in obesity and therefore as not responding adequately to the antilipolytic action of insulin (29).”
Background
Cited by
Items 201–300 of 894
Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity
Morigny, P., Houssier, M., Mairal, A., Ghilain, C., Mouisel, É., Benhamed, F., Masri, B., Recazens, E., Denechaud, P., Tavernier, G., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0007-6 · Cited by 64
Dommermuth, R., & Ewing, K. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.10.003 · Cited by 68
“The net result is hyperglycemia, TG synthesis, and overproduction of atherogenic very low-density lipoprotein particles.(12) Excess TGs deposited in ectopic tissue or visceral fat stores induce an inflammatory cascade resulting in a self-amplifying cytokine network.”
Inflammation and Metabolic Complications in HIV
Bourgi, K., Wanjalla, C. N., & Koethe, J. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0411-2 · Cited by 63
20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?
Luscombe, V. B., Lucy, D., Bataille, C. J. R., Russell, A. J., & Greaves, D. R. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5846 · Cited by 56
“Two groups to date have reported Gpr84 expression in adipose tissue or adipocytes, a key site of FFA release into the blood (Karpe et al. , 2011).”
Regnier, S. M., Kirkley, A. G., Ye, H., El-Hashani, E., Zhang, X., Neel, B. A., Kamau, W., Thomas, C. C., Williams, A. K., Hayes, E. T., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1668 · Cited by 55
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Kalra, S., Unnikrishnan, A., Baruah, M. P., Sahay, R. K., & Bantwal, G. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286888 · Cited by 63
Metabolomic biomarkers in diabetic kidney diseases—A systematic review
Zhang, Y., Zhang, S., & Wang, G. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.06.016 · Cited by 56
A weighty problem: metabolic perturbations and the obesity-cancer link
O’Flanagan, C. H., Bowers, L. W., & Hursting, S. D. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0022 · Cited by 61
“Free fatty acids leak from the engorged/necrotic adipocytes and migrate to other tissues, impairing their function and promoting inflammation, insulin resistance and diabetes [73], hypertension [74], and fatty liver disease.”
Díez‐Fernández, A., Sánchez‐López, M., Gulías‐González, R., Notario‐Pacheco, B., García-Prieto, J. C., Arias-Palencia, N. M., & Martínez‐Vizcaíno, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116506 · Cited by 61
“Our data, like those from studies that have used similar analytical techniques [32], [33], [34], support the conclusions of this review.”
ResultLiu, X., Rulina, A., Choi, M. H., Pedersen, L., Lepland, J., Takle, S. T., Madeleine, N., Peters, S. D., Wogsland, C. E., Grøndal, S. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27734-2 · Cited by 56
Dupas, J., Goanvec, C., Féray, A., Guernec, A., Alain, C., Guerrero, F., & Mansourati, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146821 · Cited by 56
“NEFA bound to plasma albumin and is transported mainly to the liver, where they are the main substrate for triglyceride synthesis [33].”
BackgroundMooranian, A., Wagle, S. R., Kovačević, B., Takechi, R., Mamo, J. C. L., Lam, V., Watts, G. F., Mikov, M., Goločorbin-Kon, S., Stojanović, G. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-53999-1 · Cited by 52
Metabolic characteristics of human subcutaneous abdominal adipose tissueafter overnight fast
Frayn, K. N., & Humphreys, S. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00527.2011 · Cited by 51
“We confirm here the well-known observation that systemic NEFA concentrations are generally higher in women than in men (32), but we did not find a significantly greater rate of NEFA release, suggesting that the difference in concentrations simply reflects the greater fat mass of women.”
BackgroundMethodResultInfluentialSelf-citationPramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2016) · Diabetes · doi:10.2337/db16-0236 · Cited by 54
“Spillover FAs derived from the peripheral lipoprotein lipase-mediated lipolysis of chylomicron-TG (14–16) may somewhat reduce but do not override this effect (13).”
BackgroundSelf-citationLanzi, S., Codecasa, F., Cornacchia, M., Maestrini, S., Salvadori, A., Brunani, A., & Malatesta, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088707 · Cited by 50
“Interestingly, higher absolute concentrations of NEFA and glycerol were found during all exercise intensities in O, suggesting that higher NEFA availability may be due to larger amounts of FM in these individuals [37].”
BackgroundCrichton, M., Marshall, S., Marx, W., Isenring, E. A., & Lohning, A. E. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac115 · Cited by 65
The contribution of sterile inflammation to the fatty liver disease and the potential therapies
Shaker, M. E. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112789 · Cited by 53
Ryberg, M., Sandberg, S., Mellberg, C., Stegle, O., Lindahl, B., Larsson, C., Hauksson, J., & Olsson, T. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12048 · Cited by 48
Liu, X., Xu, W., Cai, H., Gao, Y.-T., Li, H., Ji, B., Shu, X., Wang, T. J., Gerszten, R. E., Zheng, W., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy173 · Cited by 50
Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state
Hodson, L. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002653 · Cited by 55
“NEFA release (per unit mass) from subcutaneous abdominal (upper-body) adipose tissue has been inversely associated with fasting plasma insulin concentrations((13)).”
BackgroundRamírez-Orozco, R. E., García-Ruiz, R., Morales, P., Villalón, C. M., Villafán-Bernal, J. R., & Marichal‐Cancino, B. A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190118143014 · Cited by 51
García, N. A., González‐King, H., Grueso-Navarro, E., Sánchez, R., Martínez‐Romero, A., Jávega, B., O’Connor, J., Simons, P. J., Handberg, A., & Sepúlveda, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217546 · Cited by 49
A high-fat diet induces rapid changes in the mouse hypothalamic proteome
McLean, F. H., Campbell, F., Langston, R. F., Sergi, D., Resch, C., Grant, C., Morris, A. C., Mayer, C., & Williams, L. M. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0352-9 · Cited by 57
“concentrations of free fatty acids reported [22, 24].”
Mey, J. T., Hari, A., Axelrod, C. L., Fealy, C. E., Erickson, M. L., Kirwan, J. P., Dweik, R. A., & Heresi, G. A. (2020) · European Respiratory Journal · doi:10.1183/13993003.01700-2019 · Cited by 51
Non-esterified fatty acids in the ovary: friends or foes?
Baddela, V. S., Sharma, A., & Vanselow, J. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00617-9 · Cited by 49
“During periods of starvation/fasting, de-esterification of FAs from stored lipids of the adipose tissue takes place by the action of a hormone-sensitive lipase, resulting in the temporary elevation of NEFAs in the circulation for coping with the body’s energy demands [7, 23].”
BackgroundGomez, C. L., Santiago‐Fernández, C., García‐Serrano, S., García‐Escobar, E., Gutiérrez‐Repiso, C., Rodriguez, C., Ho‐Plagaro, A., Martín‐Reyes, F., Garrido‐Sánchez, L., Valdés, S., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082615 · Cited by 55
“However, elevated fatty acids levels are not always necessarily associated with insulin resistance [17].”
BackgroundIl-1β, Rage and Fabp4: Targeting the Dynamic Trio in Metabolic Inflammation and Related Pathologies
Hardaway, A., & Podgorski, I. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.90 · Cited by 52
Choromańska, B., Myśliwiec, P., Hady, H. R., Dadan, J., Myśliwiec, H., Chabowski, A., & Mikłosz, A. (2019) · Obesity · doi:10.1002/oby.22405 · Cited by 49
“In accordance with our finding, it has been shown that well-controlled T2DM patients do not have a higher level of FFA in plasma than healthy individuals (21).”
MethodResultEslami, M., Bahar, A., Hemati, M., Nejad, Z. R., Mehranfar, F., Karami, S., Kobyliak, N. M., & Yousefi, B. (2020) · Diabetic Medicine · doi:10.1111/dme.14415 · Cited by 50
Dietary Management of Type 2 Diabetes in the MENA Region: A Review of the Evidence
Hwalla, N. C., Jaafar, Z. A., & Sawaya, S. (2021) · Nutrients · doi:10.3390/nu13041060 · Cited by 58
“between elevated levels of NEFA and obesity has been firmly entrenched in the literature, however, a growing body of evidence is suggesting that this association may not be always true, as the predicted disparities between obese and non-obese individuals in NEFA levels and their effects on insulin resistance were show…”
BackgroundFarey, J. E., Preda, T. C., Fisher, O. M., Levert‐Mignon, A., Stewart, R. L., Karsten, E., Herbert, B. R., Swarbrick, M. M., & Lord, R. V. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2302-1 · Cited by 50
“review found no difference in fasting levels between the obese and non-obese, consistent with our findings [49].”
ResultMooranian, A., Negrulj, R., Takechi, R., Mamo, J. C. L., Al-Sallami, H. S., & Al‐Salami, H. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0473-5 · Cited by 46
Medley, K., Persons, J. L., Biswas, T., Olsen, L. A., Peuß, R., Krishnan, J., Xiong, S., & Rohner, N. (2022) · eLife · doi:10.7554/elife.74539 · Cited by 48
Houser, D. S., Champagne, C. D., & Crocker, D. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00164 · Cited by 52
Cerk, I. K., Salzburger, B., Boeszoermenyi, A., Heier, C., Pillip, C., Romauch, M., Schweiger, M., Cornaciu, I., Lass, A., Zimmermann, R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.602599 · Cited by 45
“Consequently, TG hydrolysis and synthesis are tightly regulated processes that ensure an adequate supply of FAs to oxidative tissues while avoiding FA overload in ectopic tissues (5, 6).”
BackgroundCoverdale, J. P. C., Barnett, J. P., Adamu, A. H., Griffiths, E. J., Stewart, A. J., & Blindauer, C. A. (2019) · Metallomics · doi:10.1039/c9mt00177h · Cited by 52
Zhao, L., Hutchison, A. T., Liu, B., Yates, C., Teong, X. T., Wittert, G., Thompson, C. H., Nguyen, L., Au, J., Manoogian, E. N. C., et al. (2022) · Nutrition · doi:10.1016/j.nut.2021.111583 · Cited by 50
Pátková, J., Anděl, M., & Trnka, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358709 · Cited by 52
Dandanell, S., Præst, C. B., Søndergård, S. D., Skovborg, C., Dela, F., Larsen, S., & Helge, J. W. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0518 · Cited by 46
“…and insulin resistance does not follow hand in hand as e.g. women have higher levels of FFA compared to men, Page 14 of 25 https://mc06.manuscriptcentral.com/apnm-pubs Applied Physiology, Nutrition, and Metabolism Draft 15 and at the same time they are more insulin sensitive (Karpe et al. 2011).”
BackgroundPan, D., Wang, W., Liu, N., Yang, Q., Zhang, K., Zhu, J.-Z., Shan, S., Li, Z., Ning, Z., Huang, L., et al. (2017) · PPAR Research · doi:10.1155/2017/4313561 · Cited by 47
Keskitalo, A., Munukka, E., Toivonen, R. K., Hollmén, M., Kainulainen, H., Huovinen, P., Jalkanen, S., & Pekkala, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198262 · Cited by 45
Ezeh, U., Chen, I. Y.-D., Chen, Y.-H., & Azziz, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa235 · Cited by 44
Singh, A. K., Joharapurkar, A. A., Khan, M. P., Mishra, J. S., Singh, N., Yadav, M., Hossain, Z., Khan, K., Kumar, S., Dhanesha, N. A., et al. (2014) · Diabetes · doi:10.2337/db13-1619 · Cited by 43
“NEFAs are breakdown products of TG that are released from adipocytes after lipolysis and are important in diabetic pathogenesis (45).”
BackgroundStaaf, J., Ubhayasekera, S. J. K. A., Sargsyan, E., Chowdhury, A. I., Kristinsson, H., Manell, H., Bergquist, J., Forslund, A. H., & Bergsten, P. (2016) · Pediatric Research · doi:10.1038/pr.2016.80 · Cited by 47
The role of mTOR in lipid homeostasis and diabetes progression
Chakrabarti, P., & Kandror, K. V. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000187 · Cited by 44
“Fortunately, fasting plasma fatty acid levels demonstrate a much more modest increase and are largely unrelated to body fat mass [93].”
BackgroundParry, S. A., Woods, R. M., Hodson, L., & Hulston, C. J. (2017) · Nutrients · doi:10.3390/nu9080818 · Cited by 51
“Although work from the 1960s [15,16] supports the hypothesis as elevated NEFA concentrations were observed in obesity; recent reports are not in agreement [17].”
BackgroundResultStryeck, S., Gastrager, M., Degoricija, V., Trbušić, M., Potočnjak, I., Radulović, B., Pregartner, G., Berghold, A., Madl, T., & Frank, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-42937-w · Cited by 44
Subramanian, S., Pallati, P. K., Rai, V., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2017) · Obesity · doi:10.1002/oby.21714 · Cited by 47
“Accumulation of fatty acids (25,26) can lead to increased oxidative stress and inflammatory activity (27).”
Hu, Y., Yu, J., Cui, X., Zhang, Z., Li, Q., Guo, W., Zhao, C., Chen, X., Meng, M., Yu, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.642000 · Cited by 43
Obesity-linked diabetes in the Arab world: a review
Abuyassin, B., & Laher, I. (2015) · Eastern Mediterranean Health Journal · doi:10.26719/2015.21.420 · Cited by 42
Pestana, D., Teixeira, D., Meireles, M., Marques, C., Norberto, S., Sá, C., Fernandes, V. C., Correia‐Sá, L., Faria, A., Guardão, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02885-9 · Cited by 52
The impact of triglycerides on glucose tolerance: Lipotoxicity revisited
Seghieri, M., Tricò, D., & Natali, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.04.010 · Cited by 43
Cicco, P. D., Maisto, M., Tenore, G. C., & Ianaro, A. (2020) · Nutrients · doi:10.3390/nu12123663 · Cited by 44
“The concentrations of SP used in the present study are in reference to the concentration of circulating free fatty acids in obesity [27].”
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 46
“Insulin is the master regulator of lipid metabolism; it is known to inhibit lipolysis to maintain non-esterified fatty acid (NEFA) levels by suppressing the function of hormonesensitive lipase (HSL) [49].”
BackgroundMthembu, S. X. H., Mazibuko-Mbeje, S. E., Ziqubu, K., Nyawo, T. A., Obonye, N., Nyambuya, T. M., Nkambule, B. B., Silvestri, S., Tiano, L., Muller, C. J. F., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120467 · Cited by 48
Inflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41
“When TAG is not effectively stored in adipose, NEFA can spill over, increasing circulating lipid concentrations and causing inappropriate lipid deposition in peripheral metabolic tissues((85,86)), which has detrimental consequences on metabolic and skeletal health.”
BackgroundHong, J., & Kim, Y. (2022) · Advanced Science · doi:10.1002/advs.202203286 · Cited by 46
Emerging roles of GSK-3α in pathophysiology: Emphasis on cardio-metabolic disorders
Ahmad, F., & Woodgett, J. R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118616 · Cited by 46
Steyn, F. J., Xie, T. Y., Huang, L., Ngo, S. T., Veldhuis, J. D., Waters, M. J., & Chen, C. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0084 · Cited by 45
“This relationship was verified in a recent meta-analysis of 1064 publications showing relatively stable circulating levels of NEFAs regardless of a change in BMI (Karpe et al. 2011).”
ResultTabrizi, F. P. F., Farhangi, M. A., Vaezi, M., & Hemmati, S. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00601-4 · Cited by 46
Spigoni, V., Cinquegrani, G., Iannozzi, N. T., Frigeri, G., Maggiolo, G., Maggi, M., Parello, V., & Dei, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.972890 · Cited by 43
Wang, W., Zhang, Y., Wang, Z., Zhang, J., & Jia, L. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116321 · Cited by 44
Løhr, M., Jensen, A., Eriksen, L., Grønbæk, M., Loft, S. H., & Möller, P. (2014) · Oncotarget · doi:10.18632/oncotarget.3202 · Cited by 41
“Nevertheless, it has been shown that there is a correlation between triglycerides and non-esterified fatty acids in women, whereas no such association was observed in men [30].”
BackgroundJové, M., Pradas, I., Naudí, A., Rovira‐Llopis, S., Bañuls, C., Rocha, M., Portero‐Otín, M., Hernández‐Mijares, A., Víctor, V. M., & Pamplona, R. (2017) · Oncotarget · doi:10.18632/oncotarget.23393 · Cited by 45
“In addition, FFAs are the substrate by which TAG stored in adipose tissue is transported to its sites of consumption, being the adipose tissue the only significant site of FFA release into plasma [66].”
BackgroundRoy, D., Farabaugh, K. T., Wu, J., Charrier, A., Smas, C. M., Hatzoglou, M., Thirumurugan, K., & Buchner, D. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783043 · Cited by 40
“There remains substantial debate regarding the meaning of the correlation between increased hypertrophy of adipocytes and high plasma NEFA levels in obesity (1, 3); however, as circulating lipids exceed the energy requirements of the body, higher plasma NEFA levels do contribute to the accumulation of fat in the liver…”
BackgroundObese Adipose Tissue Secretion Induces Inflammation in Preadipocytes: Role of Toll-Like Receptor-4
Renovato‐Martins, M., Moreira-Nunes, C., Atella, G. C., Barja‐Fidalgo, C., & Moraes, J. A. (2020) · Nutrients · doi:10.3390/nu12092828 · Cited by 45
“The plasma FFA concentrations in obese individuals are commonly correlated with AT expansion [9,10], which can lead to the activation of TLR2 and TLR4, increasing NF-kB activity [11], eliciting the generation of proinflammatory cytokines [12].”
Mohan, J., Ghazi, T., & Chuturgoon, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112020 · Cited by 47
“The opening of the PTPC disrupts mitochondrial processes and releases proapoptotic factors such as cytochrome c and procaspase 9 [42,43].”
BackgroundWang, Y., Law, W.-K., Hu, J., Lin, H., Ip, T.-M., & Wan, D. C. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500503b · Cited by 39
Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Hot topic: Ceramide inhibits insulin sensitivity in primary bovine adipocytes
Rico, J. E., Myers, W. A., Laub, D., Davis, A. N., Zeng, Q., & McFadden, J. W. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13983 · Cited by 38
“adipose tissue ceramide accrual and the uncontrolled lipolytic release of fatty acids are key metabolic features of heightened adiposity (Shah et al., 2008; Karpe et al., 2011).”
BackgroundFernández-Navarro, T., Díaz, I., Gutiérrez-Díaz, I., Rodríguez-Carrio, J., Suárez, A., de los Reyes-Gavilán, C. G., Gueimonde, M., Salazar, N., & González, S. (2019) · Food Research International · doi:10.1016/j.foodres.2018.12.009 · Cited by 38
VEGF‐B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content
Moessinger, C., Nilsson, I., Muhl, L., Zeitelhofer, M., Heller Sahlgren, B., Skogsberg, J., & Eriksson, U. (2020) · The EMBO Reports · doi:10.15252/embr.201949343 · Cited by 42
“Especially, non-esterified FAs (NEFAs) have been suggested to be involved in diabetes and diabetic complications ª 2020 The Authors EMBO reports 21 : e 49343 | 2020 [15,53 – 58].”
Jia, Z., Chen, X., Chen, J., Zhang, L., Oprescu, S. N., Luo, N., Xiong, Y., Yue, F., & Kuang, S. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.665 · Cited by 39
Amouzou, C., Breuker, C., Fabre, O., Bourret, A., Lambert, K., Birot, O., Fédou, C., Dupuy, A., Cristol, J., Sutra, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154119 · Cited by 39
“In accordance with the review from Karpe and colleagues [80], plasmatic levels of NEFA were in normal range for women after overnight fasting and unrelated to body fat mass and IR.”
ResultDo estrogens enhance activation of brown and beiging of adipose tissues?
Frank, A. P., Palmer, B. F., & Clegg, D. J. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.09.026 · Cited by 37
“Specifically, upper-body adipocytes isolated from lean males and females are highly responsive to lipolytic adrenergic stimulation when compared to lower body adipocytes (Karpe et al., 2011; Wahrenberg et al., 1989), and these effects were more pronounced in females.”
BackgroundLee, Y., Kim, S., Yuk, H. J., Lee, G., & Kim, D.-S. (2018) · Nutrients · doi:10.3390/nu10081087 · Cited by 37
“Fatty acids secreted from adipose tissue enter the liver to synthesize fatty acids and TG, which may cause fatty liver and hyperlipidemia by changing the lipid profile in the plasma [20].”
BackgroundWagle, S. R., Walker, D., Kovačević, B., Gedawy, A., Mikov, M., Goločorbin-Kon, S., Mooranian, A., & Al‐Salami, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-64355-z · Cited by 37
Beaulieu, J., Costa, G., Renaud, J., Moitié, A., Glémet, H., Sergi, D., & Martinoli, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02328-7 · Cited by 42
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 40
Pathak, V., Vasu, S., Gault, V. A., Flatt, P. R., & Irwin, N. (2015) · Diabetologia · doi:10.1007/s00125-015-3653-1 · Cited by 37
“The enhancement of insulin sensitivity is also likely to reflect upregulation of insulin receptors consequent to alleviation of hyperinsulinaemia [28].”
BackgroundNgo, T. D., Ryu, B. H., Ju, H., Jang, E., Park, K., Kim, K. K., & Kim, T. D. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913013425 · Cited by 36
“Its pivotal role in lipolysis has drawn attention to HSL as a potential pharmaceutical target, because fatty-acid levels influence the pathogenesis of type II diabetes, obesity and cardiovascular diseases (Cascio et al., 2012; Karpe et al., 2011).”
BackgroundStructural insights of a hormone sensitive lipase homologue Est22
Huang, J., Huo, Y., Ji, R., Kuang, S., Ji, C., Xu, X., & Li, J. (2016) · Scientific Reports · doi:10.1038/srep28550 · Cited by 36
Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes
Capel, F., Cheraïti, N., Acquaviva, C., Hénique, C., Bertrand‐Michel, J., Vianey‐Saban, C., Prip‐Buus, C., & Morio, B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.10.002 · Cited by 40
Bergouignan, A., Gozansky, W. S., Barry, D. W., Leitner, W., MacLean, P. S., Hill, J. O., Draznin, B., & Melanson, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030164 · Cited by 36
“[46] that although lipolysis and FFA delivery under fasting conditions is downregulated in obesity, an elevation in fasting FFA is observed in some obese individuals.”
BackgroundParry, S. A., Smith, J. R., Corbett, T. R. B., Woods, R. M., & Hulston, C. J. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114516004475 · Cited by 40
John, A. N., & Jiang, F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.12.002 · Cited by 43
Kopp, W. (2018) · Nutrition and Metabolic Insights · doi:10.1177/1178638818773072 · Cited by 39
Li, W., Wan, H., Yan, S., Zhao, Y., Chen, Y., Guo, P., Ramesh, T., Cui, Y., & Ning, L. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.04.031 · Cited by 38
Approach to the Patient With Lipodystrophy
Fourman, L. T., & Grinspoon, S. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac079 · Cited by 39
Heparanase Accelerates Obesity-Associated Breast Cancer Progression
Hermano, E., Goldberg, R., Rubinstein, A. M., Sonnenblick, A., Maly, B., Nahmias, D., Li, J., Bakker, M. A. H., van der Vlag, J., Vlodavsky, I., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4058 · Cited by 38
Jönsson, C., Castor Batista, A. P., Kjølhede, P., & Strålfors, P. (2019) · Biochemical Journal · doi:10.1042/bcj20190594 · Cited by 34
Influence of endogenous NEFA on beta cell function in humans
Rebelos, E., Seghieri, M., Natali, A., Balkau, B., Golay, A., Piatti, P. M., Lalic, N. M., Laakso, M., Mari, A., & Ferrannini, E. (2015) · Diabetologia · doi:10.1007/s00125-015-3685-6 · Cited by 39
Role of Dietary Fats in the Prevention and Treatment of the Metabolic Syndrome
Nettleton, J. A., Jebb, S., Risérus, U., Koletzko, B., & Fleming, J. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000363510 · Cited by 34
Diet and Metabolic Syndrome: An Overview
Keane, D., Kelly, S., Healy, N. P., McArdle, M. A., Holohan, K., & Roche, H. M. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660173 · Cited by 42
Sex and Gender Differences in Body Composition, Lipid Metabolism, and Glucose Regulation
Ethun, K. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802388-4.00009-4 · Cited by 46
Rajaraman, G., Simcocks, A. C., Hryciw, D. H., Hutchinson, D. S., & McAinch, A. J. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500449 · Cited by 40
Vorotnikov, A. V., Stafeev, I., Menshikov, M. Y., Shestakova, M. V., & Parfyonova, Y. V. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919110099 · Cited by 38
Kdekian, A., Alssema, M., van der Beek, E. M., Greyling, A., Vermeer, M. A., Mela, D. J., & Trautwein, E. A. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0534-6 · Cited by 35
“insulin is then released in the blood [34].”
Background‘Micro‐managers’ of hepatic lipid metabolism and NAFLD
Liu, W., Cao, H., Yan, J., Huang, R., & Ying, H. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1295 · Cited by 37
Holven, K. B., Retterstøl, K., Ueland, T., Ulven, S. M., Nenseter, M. S., Sandvik, M., Narverud, I., Berge, K. E., Ose, L., Aukrust, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078241 · Cited by 39
“The increase level of FFA among the high cholesterol subjects is most likely due to the increased number of female subjects in the high cholesterol group [18–19].”
Metadata
- Authors
- Karpe, F., Dickmann, J. R., & Frayn, K. N.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-09-16
- Volume
- 60
- Issue
- 10
- Pages
- 2441-2449
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3178283
- OpenAlex
- W2152688545
- Cited by
- 896
- References
- 91
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 73 · 2021: 72 · 2020: 76 · 2019: 74 · 2018: 68 · 2017: 85 · 2016: 76 · 2015: 78 · 2014: 57 · 2013: 53 · 2012: 31
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Oxford
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- free fatty acids, obesity, insulin resistance, adipose tissue lipolysis, fatty acid mobilization, plasma albumin binding, triacylglycerol mobilization, insulin signaling
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.